Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Ejhaem|July 18, 2022
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myelomaThomas Martin, Amrita Krishnan, Kwee Yong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2009
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcomeJason A Coppell, Paul G Richardson, Robert Soiffer, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
British Journal of Haematology|February 26, 2013
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myelomaPeter M Voorhees, Robert F Manges, Pieter Sonneveld, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With TalquetamabAjai Chari, Amrita Krishnan, Leo Rasche, et al.
JAMA Cardiology|November 8, 2023
Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell TransplantJune-Wha Rhee, Raju Pillai, Tianhui He, et al.
Plos One|June 28, 2013
Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult ZebrafishWei-Chang Huang, Chung-Chi Yang, I-Hui Chen, et al.
Pageof 16